StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) stock

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.47−0.04 (-2.69%)

Close on Nov 19, 2026Market cap $1.92MP/E –Yield –

Can-Fite BioPharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Can-Fite BioPharma

Can-Fite BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Can-Fite BioPharma figures

See a number that looks wrong?